Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

5(71.4%)

Phase 1

2(28.6%)

7Total

N/A(5)

Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05879835Not ApplicableRecruiting

KiteLock 4% EDTA Lock Solution for the Prevention of Occlusions in Children With Intestinal Failure

Role: collaborator

NCT06996301Not ApplicableCompleted

Clinical Utility of a PCR Compared to Culture and Sensitivity Testing for the Management of cUTI in Adults.

Role: collaborator

NCT07122349Not ApplicableCompleted

Cannabis Impairment Detection Device Study

Role: collaborator

NCT04910061Not ApplicableCompleted

Safety and Pharmacokinetics of Nicotinamide Mononucleotide (NMN) in Healthy Adults.

Role: collaborator

NCT05242718Not ApplicableCompleted

Immune Diversity Response to Oral Dosing of Nutritional Health Products in Healthy Participants

Role: collaborator

NCT01887834Phase 1Completed

Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome

Role: collaborator

NCT01176227Phase 1Completed

Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome (IBS)

Role: collaborator

All 7 trials loaded